Treace Medical Concepts, Inc. TMCI Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $47.2M-24.5% | $62.52M+24.5% | $50.21M+6.0% | $47.39M-9.9% | $52.57M-23.5% | ||
| $9.79M-19.2% | $12.12M+15.3% | $10.51M+9.1% | $9.64M-9.8% | $10.68M-19.3% | ||
| $37.41M-25.8% | $50.4M+26.9% | $39.71M+5.2% | $37.75M-9.9% | $41.89M-24.5% | ||
| 79.3%-1.4pp | 80.6%+1.5pp | 79.1%-0.6pp | 79.7%0.0pp | 79.7%-1.1pp | ||
| $4.62M+1.8% | $4.54M-2.9% | $4.68M-14.9% | $5.5M-1.2% | $5.56M+6.8% | ||
| $33.78M-9.3% | $37.25M+8.2% | $34.42M+4.0% | $33.08M-8.4% | $36.12M-2.0% | ||
| $16.18M+11.4% | $14.53M-10.8% | $16.28M+0.8% | $16.14M+2.2% | $15.79M+16.0% | ||
| $54.57M-3.1% | $56.32M+1.7% | $55.38M+1.2% | $54.73M-4.8% | $57.48M+3.2% | ||
| $54.57M-3.1% | $56.32M+1.7% | $55.38M+1.2% | $54.73M-4.8% | $57.48M+3.2% | ||
| -$17.17M-190% | -$5.92M+62.2% | -$15.68M+7.6% | -$16.97M-8.9% | -$15.58M-7,538% | ||
| -36.4%-26.9pp | -9.5%+21.7pp | -31.2%+4.6pp | -35.8%-6.2pp | -29.6%-29.3pp | ||
| $1.57M+16.3% | $1.35M+0.9% | $1.34M+1.3% | $1.32M+0.8% | $1.31M-0.2% | ||
| $501K-4.9% | $527K-16.9% | $634K-18.2% | $775K-7.8% | $841K-6.5% | ||
| -$794K+77.1% | -$3.47M-467% | -$612K-44.3% | -$424K-24.7% | -$340K-14.5% | ||
| -$17.96M-91.2% | -$9.39M+42.3% | -$16.29M+6.4% | -$17.4M-9.3% | -$15.92M-3,078% | ||
| -38.1%-23.0pp | -15%+17.4pp | -32.4%+4.3pp | -36.7%-6.4pp | -30.3%-29.6pp | ||
| -$0.28-100% | -$0.14+46.2% | -$0.26+7.1% | -$0.28-12.0% | -$0.25-2,400% | ||
| -$0.28-100% | -$0.14+46.2% | -$0.26+7.1% | -$0.28-12.0% | -$0.25-2,400% | ||
| 64.6M+2.1% | 63.3M-0.4% | 63.5M+0.8% | 63M+0.6% | 62.7M+0.9% | ||
| 64.6M+2.1% | 63.3M-0.4% | 63.5M+0.8% | 63M+0.6% | 62.7M+0.9% | ||
| -$18.06M-92.0% | -$9.41M+42.1% | -$16.26M+6.6% | -$17.41M-9.0% | -$15.96M-2,583% | ||
| $501K-4.9% | $527K-16.9% | $634K-18.2% | $775K-7.8% | $841K-6.5% | ||
| -$794K+77.1% | -$3.47M-467% | -$612K-44.3% | -$424K-24.7% | -$340K-14.5% | ||
| $275K+213% | $88K-4.3% | $92K-24.6% | $122K-6.2% | $130K+10.2% | ||
| -$17.17M-190% | -$5.92M+62.2% | -$15.68M+7.6% | -$16.97M-8.9% | -$15.58M-7,538% | ||
| -$16.27M-422% | -$3.11M+75.9% | -$12.9M+10.4% | -$14.4M-9.7% | -$13.12M-745% | ||
| -$16.27M-422% | -$3.11M+75.9% | -$12.9M+10.4% | -$14.4M-9.7% | -$13.12M-745% | ||
| -34.5%-29.5pp | -5%+20.7pp | -25.7%+4.7pp | -30.4%-5.4pp | -25%-27.9pp | ||
| -$17.17M-190% | -$5.92M+62.2% | -$15.68M+7.6% | -$16.97M-8.9% | -$15.58M-7,538% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Treace Medical Concepts, Inc.'s revenue?
- Treace Medical Concepts, Inc. (TMCI) generated $207.3M in revenue over the trailing twelve months, down 1.7% year over year.
- Is Treace Medical Concepts, Inc. profitable?
- Treace Medical Concepts, Inc. is not currently profitable: it reported a net loss of $61.0M over the trailing twelve months, a -29.4% net margin.
- What are Treace Medical Concepts, Inc.'s profit margins?
- Gross margin is 79.7% and operating margin is -26.9%, with a -29.4% net margin.
- What is Treace Medical Concepts, Inc.'s earnings per share?
- Treace Medical Concepts, Inc.'s diluted EPS over the trailing twelve months is $-0.96.
- Where does Treace Medical Concepts, Inc.'s income statement data come from?
- Every line is extracted from Treace Medical Concepts, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
